ID Flashcards
1
Q
A
2
Q
HSV encephalitis test
A
HSV PCR
3
Q
West Nile Neuroinvasive Disease Test
A
Serum and CSF IgM
4
Q
A
5
Q
A
6
Q
A
7
Q
A
8
Q
A
9
Q
A
10
Q
Treatment for Lyme Disease
A
11
Q
Babesia treatment
A
12
Q
UTI treatment (complicated/pregnant)
A
13
Q
A
14
Q
TB treatment
A
15
Q
Treatment of MAC
A
16
Q
Treatment for Aspergillosis
A
17
Q
Treatment for Candida
A
18
Q
Treatment of Cryptococcus
A
19
Q
A
20
Q
Treatment of gonnorrhea/chlamydia
A
21
Q
Treatment of PID
A
22
Q
Treatment of Syphyllis
A
23
Q
HPV treatment
A
24
Q
Testing for complement deficiency
A
25
26
Anthrax Treatment
27
Tularemia Treatment
28
Malaria Prevention
29
30
Transplant Infections
31
Transplant Infection treatment
32
Catheter Assoicated Infection Treatment
33
HIV post-exposure prophylaxis
34
35
PJP treatment
36
Toxoplosmosis Treatment
37
EBV symptoms
38
Possible vs probable or confirmed encephalitis criteria
Possible: one major nd two minor criteria
probable or confirmed: one major and at least three minor criteria.
Major: altered consciousness for more than 24 hours
minor: fever, new-onset seizure, new-onset focal neurologic findings, CSF pleocytosis, and abnormal MRI or electroencephalographic finding
39
complicated UTI definitions (x7)
UTIs in men, pregnant women, and persons with foreign bodies (for example, indwelling catheters, calculi), kidney disease, immunocompromise, obstruction, urinary retention from neurologic disorders, health care–associated infections, or recent antibiotic use are considered to be complicated.
40
evaluation of classic FUO
complete blood count with differential, electrolyte levels, kidney and liver function tests (hepatitis serology if results are abnormal), lactate dehydrogenase level, urinalysis or microscopy and urine culture, erythrocyte sedimentation rate, C-reactive protein, antinuclear antibodies, rheumatoid factor, HIV testing, cytomegalovirus polymerase chain reaction testing, blood cultures (three sets, each set obtained at least several hours apart), tuberculosis testing, and chest radiography (or chest CT). Q-fever serology should be considered if risk factors exist, and mycobacterial blood cultures should be obtained in HIV-positive patients with CD4 cell counts of 50/µL or less.
If initial tests do not suggest a cause, abdominal or pelvic CT may be considered to evaluate for intra-abdominal abscess or lymphoproliferative disorders.
41
P. Falciparum morphology on smear
42
Malaria resistent to chloroquine
P. vivax
P. falciparum
P. malariae(rare)
43
Treatment of Cryptosporidium
supportive care for most immunocompetent hosts; nitazoxanide is recommended for severe or prolonged infection or if supportive care does not resolve symptoms; antiretroviral therapy is most effective in resolving infection in HIV-infected patients.
44
Cyclospora Treatment
Bactrim
45
Entamoeba histolytica treatment
metronidazole or tinidazole is recommended initially for parasitic clearance followed by an intraluminal amebicide, such as paromomycin or diloxanide
46
risk factors for antibiotic resistance
previous intravenous antibiotics within 90 days, septic shock at the time of VAP diagnosis, acute respiratory distress syndrome preceding VAP, 5 or more days of hospitalization before developing VAP, and dialysis before VAP onset.
